Navigation Links
OncoGenex Reports Second Quarter Financial Results
Date:8/5/2010

$ 1,701 $ - $ 6,401 $ - Operating expenses Research and development 3,079 3,588 9,459 5,282 General and administrative 1,475 1,003 2,825 1,785 Total operating expenses 4,554 4,591 12,284 7,067 Other income (expense) 7 34 (7) 91 Loss for the period before taxes 2,846 4,557 5,890 6,976 Income tax expense (recovery) (3,000) 6 (3,000) (4) Net income (loss) $ 154 ($ 4,563) ($ 2,890) ($ 6,972) Condensed Consolidated Balance Sheets (in thousands) June 30, December 31, 2010 2009 (unaudited) Assets: Cash, cash equivalents and short term investments $ 47,304 $ 64,568 Restricted cash 502 - Amounts receivable 413 3,109 Prepaid and other current assets 2,341 722 Property, equipment and other assets 582 581 ------------------------ Total assets 51,142 $ 68,980 ------------------------ ------------------------ Liabilities and stockholders' equity: Accounts payable and accrued expenses 1,667 $ 14,453 Deferred collaboration revenue 24,135 26,528 Other current liabilities 1,278
'/>"/>
SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. OncoGenex Pharmaceuticals Announces Initiation of a Phase 3 Trial in Men with Metastatic Prostate Cancer
2. OncoGenex Pharmaceuticals to Present at the 9th Annual Needham Healthcare Conference
3. OncoGenex Reports First Quarter Financial Results
4. OncoGenex Pharmaceuticals to Webcast Discussion of Financial Results for Fourth Quarter and Fiscal Year 2009
5. OncoGenex Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
6. Teva Expands Innovative Pipeline with License Agreement to Develop and Commercialize OncoGenex Late Stage Innovative Treatment for Multiple Oncology Indications
7. OncoGenex Pharmaceuticals to Host Investor Conference Call at 8:30 a.m. ET, December 21, 2009
8. OncoGenex Reports Third Quarter 2009 Financial Results
9. OncoGenex Pharmaceuticals to Release Third Quarter 2009 Financial Results
10. OncoGenex Pharmaceuticals CEO Named Canadas Pacific Ernst & Youngs Entrepreneur Of The Year(R) in the Health Sciences Category
11. OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... (PRWEB) September 18, 2014 Leatherwood ... FM-4910 listed material, to stay competitive in the ... These high-performance materials ultimately impact product quality and ... and owner. , Established in 1980 in Lewisville, ... as many fabricators have left the business. Much ...
(Date:9/18/2014)...  MEI Pharma, Inc. (Nasdaq: MEIP ), an ... for cancer, announced today that Daniel P. Gold , ... NewsMakers in the Biotech Industry conference on Friday, ... Millennium Broadway Hotel & Conference Center in New ... be accessed at www.meipharma.com . A replay will be ...
(Date:9/18/2014)... /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY ) ... separate underwritten offerings of 10,000,000 shares of its Common ... per share, for expected gross proceeds of $20 million ... Stock at a price to the public of $2,000.00 ... Each share of Series A Convertible Preferred Stock is ...
(Date:9/18/2014)... , Sept. 18, 2014   Sigma-Aldrich ... it has entered into a new gene editing ... School,s Vector Core. Under the partnership, Sigma-Aldrich will ... experimental design consultation, and dedicated gene editing bioinformaticians. ... gene editing-based research at the U-M Medical School. ...
Breaking Biology Technology:Leatherwood Plastics Selects Vycom’s Flametec PVC-C Material to Stay Competitive in Semiconductor and Lab Equipment Industries 2MEI Pharma To Present At BioCentury's NewsMakers Conference 2MEI Pharma To Present At BioCentury's NewsMakers Conference 3Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 3Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 2Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 3Sigma-Aldrich, University of Michigan Medical School Establish CRISPR Core Lab Partnership 4
... in pregnancy (NVP) is the most common medical condition in ... women.(1) Yet in a recent national survey of more than ... experiencing NVP in the last 12 months, pointing to the ... condition.    The survey was conducted online in ...
... the University of Jyvskyl, Finland, and at Harvard University, US, ... simulations, the researchers have been able to predict that long ... by means of twisting. The research has received funding from ... and easily explained: just twist the ends of a strap ...
... Accelerator), designed to grow health care IT companies in ... in partnership with a number of Cleveland region health ... for emerging companies recognizes the growing interest in and ... "The H.I.T. Accelerator is a new approach to ...
Cached Biology Technology:Morning Sickness or NVP: National Survey of Nurse Practitioners Points to Underreporting of Common Condition in Pregnancy 2Morning Sickness or NVP: National Survey of Nurse Practitioners Points to Underreporting of Common Condition in Pregnancy 3Morning Sickness or NVP: National Survey of Nurse Practitioners Points to Underreporting of Common Condition in Pregnancy 4Morning Sickness or NVP: National Survey of Nurse Practitioners Points to Underreporting of Common Condition in Pregnancy 5Healthcare IT Accelerator Launched 2Healthcare IT Accelerator Launched 3
(Date:9/19/2014)... Nxt-ID, Inc. (Nasdaq: NXTD and NXTDW) ... growing m-commerce market, updates the "Wocket in Your Pocket" celebrity ad ... light middleweight weight classes, Vinny Pazienza (PAZ). ... Game of Thrones actor Ciaran Hinds and ... Katey Sagal have been cast in Bleed for ...
(Date:9/18/2014)... A new GSA Bulletin study uses tree ... Puerco and Chaco Wash in northern New Mexico, USA. ... cedar and willow, investigators were able to precisely date ... then combined this data with aerial imagery, LiDAR, longitudinal ... these arroyos. , Arroyos are deep, oversized channels that ...
(Date:9/18/2014)... 18, 2014 New research into the Crimean-Congo hemorrhagic ... severe hemorrhagic disease in humans similar to that caused ... CCHFV infection. This discovery has the potential to lead ... , The research, reported in a paper ... and conducted by scientists at the Texas Biomedical Research ...
Breaking Biology News(10 mins):NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 2NXT-ID's Vinny Paz Celebrity Ad Wocket Update: Katey Sagal and Ciaran Hinds Attached to His Upcoming Movie 3Tree rings and arroyos 2Tree rings and arroyos 3Tree rings and arroyos 4Tree rings and arroyos 5Tree rings and arroyos 6Tree rings and arroyos 7Research milestone in CCHF virus could help identify new treatments 2
... role in seagrass fields. Dutch researcher Arie Vonk ... He discovered that the interaction between seagrasses, animals ... in tropical seagrass fields. Consequently the nitrogen lost ... fields are coastal ecosystems with important functions for ...
... There are only four specimens of the Yangtze giant ... three in captivity. In order to save this species ... (WCS) and the Turtle Survival Alliance (TSA), working in ... China Zoo Society, recently paired two of them. ...
... will present findings on a variety of NASA-related ... Assembly of the American Geophysical Union. The meeting ... at the Greater Fort Lauderdale-Broward County Convention Center, ... open to registered news media. Following are ...
Cached Biology News:Nitrogen retained through loss 2Relocation of endangered Chinese turtle may save species 2NASA presentations at American Geophysical Union Joint Assembly 2NASA presentations at American Geophysical Union Joint Assembly 3NASA presentations at American Geophysical Union Joint Assembly 4NASA presentations at American Geophysical Union Joint Assembly 5